Moduladores enzimáticos
Moduladores de enzimas são compostos que podem aumentar ou inibir a atividade de enzimas, regulando assim a taxa de reações bioquímicas. Esses moduladores desempenham um papel crucial no controle de vias metabólicas, sinalização celular e vários processos fisiológicos. Os moduladores de enzimas são amplamente utilizados em pesquisa e desenvolvimento de medicamentos para estudar as funções enzimáticas e desenvolver agentes terapêuticos. Na CymitQuimica, oferecemos uma ampla gama de moduladores de enzimas de alta qualidade para apoiar sua pesquisa em regulação enzimática e descoberta de medicamentos.
Subcategorias de "Moduladores enzimáticos"
Foram encontrados 693 produtos de "Moduladores enzimáticos"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
BMS 794833
CAS:<p>ATP-competitive inhibitor of Met and VEGFR2</p>Fórmula:C23H15ClF2N4O3Pureza:Min. 95%Peso molecular:468.84 g/molPanobinostat
CAS:<p>Inhibitor of histone deacetylases</p>Fórmula:C21H23N3O2Pureza:Min. 97.5 Area-%Cor e Forma:Off-White Slightly Brown Yellow PowderPeso molecular:349.43 g/molDabrafenib
CAS:<p>Inhibitor of mutant B-rafV600E protein that results in decreased proliferation of cancer cells with this mutation. Treatment of metastatic melanoma in patients harboring the V600E mutation, had improved disease outcome. This antitumor activity is enhanced when combined with MEK inhibitor trametinib.</p>Fórmula:C23H20F3N5O2S2Pureza:Min. 95%Cor e Forma:PowderPeso molecular:519.56 g/molGSK 126
CAS:<p>GSK-126 is a potent inhibitor of histone lysine methyl transferase 2, which is encoded by the enhancer of zeste homolog 2 gene (EZH2). The EZH2 protein regulates cell cycle as it represses the Polycomb-Repressive Complex 2 (PRC2), allowing cells to divide actively. GSK-126 inhibits the EZH2 by targeting the catalytic domain (SET) of the enzyme and therefore blocks the PCR2 repression mechanism, resulting in cell proliferation arrest. The compound has shown therapeutic potential for a variety of cancers.</p>Fórmula:C31H38N6O2Pureza:Min. 95%Cor e Forma:White To Yellow SolidPeso molecular:526.30562Brigatinib
CAS:<p>Pan-ALK receptor tyrosine kinase inhibitor</p>Fórmula:C29H39ClN7O2PPureza:Min. 98 Area-%Cor e Forma:White PowderPeso molecular:584.09 g/molImidapril hydrochloride
CAS:<p>Angiotensin-converting enzyme inhibitor</p>Fórmula:C20H28ClN3O6Pureza:Min. 95%Cor e Forma:White To Off-White SolidPeso molecular:441.16666Nilotinib - Bio-X ™
CAS:<p>Nilotinib is tyrosine kinase inhibitor drug that is used to treat chronic myeloid leukemia (CML). It inhibits the activity of the BCR-ABL protein kinase, which is involved in the development of CML. Additionally, it inhibits PDGF and c-kit for the potential treatment of various leukemias.</p>Fórmula:C28H22F3N7OPureza:Min. 95%Cor e Forma:PowderPeso molecular:529.52 g/molAbemaciclib mesylate
CAS:<p>Inhibits cyclin-dependent kinase 4 and 6 (CDK4 and CDK6); antineoplastic</p>Fórmula:C27H32F2N8•CH4O3SPureza:Min. 95%Cor e Forma:White PowderPeso molecular:602.7 g/molArgatroban monohydrate
CAS:<p>A reversible and selective inhibitor of thrombin that rapidly binds to the catalytic site directly. Inhibits both soluble and bound forms of thrombin. Used for prophylaxis and treatment of heparin-induced thrombocytopenia type II.</p>Fórmula:C23H36N6O5S•H2OPureza:Min. 95%Cor e Forma:PowderPeso molecular:526.65 g/molAS 1949490
CAS:<p>Inhibitor of SHIP2 phosphatase</p>Fórmula:C20H18ClNO2SPureza:Min. 95%Cor e Forma:SolidPeso molecular:371.88 g/molAminoglutethimide - Bio-X ™
CAS:Produto Controlado<p>Aminoglutethimide is an adrenocortical steroid synthesis inhibitor that is used for the treatment of Cushing’s syndrome. This drug is an aromatase inhibitor that blocks the production of adrenal steroids. Also, this drug blocks the conversion of androgens to estrogens. Aminoglutethimide has been studied for the treatment of cancers such as breast and prostate.</p>Fórmula:C13H16N2O2Pureza:Min. 95%Cor e Forma:PowderPeso molecular:232.28 g/molYM155
CAS:<p>A novel survivin suppressant with an IC50 of 0.54 nM for the negative regulation of the survivin promoter.</p>Fórmula:C20H19BrN4O3Pureza:Min. 95%Cor e Forma:Off-White PowderPeso molecular:443.29 g/molNeratinib maleate
CAS:<p>Irreversible ErbB receptor tyrosine kinase inhibitor</p>Fórmula:C30H29ClN6O3·C4H4O4Pureza:Min. 98 Area-%Cor e Forma:White PowderPeso molecular:673.11 g/molSP 2509
CAS:<p>Lysine-specific demethylase 1 ( LSD1) antagonist</p>Fórmula:C19H20ClN3O5SPureza:(Hplc) Min. 98.0%Cor e Forma:PowderPeso molecular:437.9 g/molAmino tadalafil
CAS:<p>Tadalafil analogue; PDE 5 inhibitor</p>Fórmula:C21H18N4O4Pureza:Min. 95%Cor e Forma:PowderPeso molecular:390.39 g/molAtaciguat
CAS:<p>Activator of soluble guanylyl cyclase (sGC) which stimulates cGMP production and is effective in cells under oxidative stress. Ataciguat stimulates the heme-free form of the sGC enzyme via the sGC N-terminus of β1-subunit. Ataciguat can promote vasorelaxation and hypotension by restoring or potentiating the nitric oxide (NO) signalling pathway.</p>Fórmula:C21H19Cl2N3O6S3Pureza:Min. 95%Cor e Forma:PowderPeso molecular:576.5 g/molRanolazine - Bio-X ™
CAS:<p>Ranolazine is a group P2 drug that reverses the pathogenic mechanism of myocardial infarction. It is used to treat chronic angina. It decreases myocardial wall tension and improves coronary blood flow. It inhibits the ryanodine receptor, which is responsible for regulating the release of intracellular calcium in cardiac and skeletal muscle cells. Furthermore, it is also effective at preventing atrial fibrillation and has been studied as monotherapy as well as in combination with other medications used to treat irregular heartbeat.</p>Fórmula:C24H33N3O4Pureza:Min. 95%Cor e Forma:PowderPeso molecular:427.54 g/molrac-Perhexiline maleate
CAS:<p>Inhibitor of CPT1 and CPT2 enzymes; inhibitor of mTORC1 kinase; anti-fungal</p>Fórmula:C23H39NO4Pureza:Min. 97 Area-%Cor e Forma:White To Off-White SolidPeso molecular:393.56 g/molJNJ 38877605
CAS:<p>Potent inhibitor of c-Met catalytic activity. Selective over other tyrosine and serine-threonine kinases (600-fold selectivity). Ability to block constitutive or HGF-stimulated phosphorylation of c-Met demonstrated in vitro. JNJ 38877605 reduces radiation-induced invasion, apoptosis and proliferation of cancer cells in vitro.</p>Fórmula:C19H13F2N7Pureza:Min. 95%Cor e Forma:SolidPeso molecular:377.12005Dabrafenib mesylate
CAS:<p>Inhibitor of B-Raf kinase mutant</p>Fórmula:C23H20F3N5O2S2·CH4O3SPureza:Min. 95%Cor e Forma:White/Off-White SolidPeso molecular:615.67
